![Robert Michael Richey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Michael Richey
Corporate Officer/Principal bij Halteres Associates LLC
Actieve functies van Robert Michael Richey
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Halteres Associates LLC
![]() Halteres Associates LLC Medical/Nursing ServicesHealth Services Halteres Associates LLC is a consulting firm founded in 2002 and based in an undisclosed location. The American company provides strategic and tactical consulting services to organizations in the areas of diagnostics, health, medical devices, and life science research. The private company leverage a robust network of industry professionals across multiple disciplines to assist organizations with technology creation and applications, product and market development, opportunity and economic analyses, business modeling, and more. The company's clients include large multinational companies, nongovernmental organizations, and emerging industry innovators. Halteres Associates is passionate about improving healthcare and can help create impact and value by matching medical innovation to market needs. | Corporate Officer/Principal | - | - |
Loopbaan van Robert Michael Richey
Eerdere bekende functies van Robert Michael Richey
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DIADEXUS, INC. | Corporate Officer/Principal | 12-10-2011 | 30-09-2014 |
Tethys Bioscience, Inc.
![]() Tethys Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Tethys Bioscience was dedicated to the discovery, development and commercialization of novel biological markers biomarkers that provided a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes. By developing new tests that used protein and other blood borne biomarkers to identify people at high risk for devastating and preventable diseases, they can arm patients and physicians with knowledge they can use to help prevent disease progression. These biomarkers gave a snapshot of an individual's current risk, which may be modifiable. Their goal was to provide clinicians with an objective and convenient means to risk-stratify their patients and help them focus appropriate intervention strategies on those most likely to benefit. Their research strategies lead to sets of biomarkers that can be used to quantify the level of an individual's risk. The company had become a pioneer in the discovery, development and value creation of novel biological markers for the clinical diagnostics marketplace: The company had built expertise, created significant intellectual property, and was executing its business plan around three key areas: Biomarker Discovery, Clinical Validation and ValueCreation. It was focused upon introducing products that yield significant savings to the health care system and improve the quality of life for patients. | Corporate Officer/Principal | 01-01-2005 | 01-09-2009 |
President | 01-09-2009 | - | |
Chiron Diagnostics Corp.
![]() Chiron Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Bayer AG, Chiron Diagnostics Corp. is a company that develops medical diagnostic products. The company is based in East Walpole, MA. Chiron Diagnostics was acquired by Bayer AG from Chiron Corp. on November 30, 1998 for $1,100 million. | Verkoop & Marketing | - | - |
Zyomyx, Inc.
![]() Zyomyx, Inc. Medical SpecialtiesHealth Technology Zyomyx, Inc. manufactured point-of-care diagnostic devices based on cell-counting technology. It engaged in the development and commercialization of diagnostic platforms. The firm offered disposable CD4 T-cell, a point-of-care test for HIV and AIDS treatment. The company was founded by Peter Wagner, Steffen Nock, Christian Itin, and Dana Ault-Riche in 1998 and was headquartered in Fremont, CA. | Directeur/Bestuurslid | 01-01-2011 | - |
Opleiding van Robert Michael Richey
University of Oklahoma | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Corporate Officer/Principal | 3 |
President | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Tethys Bioscience, Inc.
![]() Tethys Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Tethys Bioscience was dedicated to the discovery, development and commercialization of novel biological markers biomarkers that provided a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes. By developing new tests that used protein and other blood borne biomarkers to identify people at high risk for devastating and preventable diseases, they can arm patients and physicians with knowledge they can use to help prevent disease progression. These biomarkers gave a snapshot of an individual's current risk, which may be modifiable. Their goal was to provide clinicians with an objective and convenient means to risk-stratify their patients and help them focus appropriate intervention strategies on those most likely to benefit. Their research strategies lead to sets of biomarkers that can be used to quantify the level of an individual's risk. The company had become a pioneer in the discovery, development and value creation of novel biological markers for the clinical diagnostics marketplace: The company had built expertise, created significant intellectual property, and was executing its business plan around three key areas: Biomarker Discovery, Clinical Validation and ValueCreation. It was focused upon introducing products that yield significant savings to the health care system and improve the quality of life for patients. | Health Technology |
Diadexus, Inc.
![]() Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Zyomyx, Inc.
![]() Zyomyx, Inc. Medical SpecialtiesHealth Technology Zyomyx, Inc. manufactured point-of-care diagnostic devices based on cell-counting technology. It engaged in the development and commercialization of diagnostic platforms. The firm offered disposable CD4 T-cell, a point-of-care test for HIV and AIDS treatment. The company was founded by Peter Wagner, Steffen Nock, Christian Itin, and Dana Ault-Riche in 1998 and was headquartered in Fremont, CA. | Health Technology |
Chiron Diagnostics Corp.
![]() Chiron Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Bayer AG, Chiron Diagnostics Corp. is a company that develops medical diagnostic products. The company is based in East Walpole, MA. Chiron Diagnostics was acquired by Bayer AG from Chiron Corp. on November 30, 1998 for $1,100 million. | Health Technology |
Halteres Associates LLC
![]() Halteres Associates LLC Medical/Nursing ServicesHealth Services Halteres Associates LLC is a consulting firm founded in 2002 and based in an undisclosed location. The American company provides strategic and tactical consulting services to organizations in the areas of diagnostics, health, medical devices, and life science research. The private company leverage a robust network of industry professionals across multiple disciplines to assist organizations with technology creation and applications, product and market development, opportunity and economic analyses, business modeling, and more. The company's clients include large multinational companies, nongovernmental organizations, and emerging industry innovators. Halteres Associates is passionate about improving healthcare and can help create impact and value by matching medical innovation to market needs. | Health Services |